Home / Inspections / 655413

FDA Inspection 655413 — Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc — FEI 1000514603

The FDA completed an inspection of Regeneron Pharmaceuticals Inc on March 31, 2010 in Rensselaer, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 31, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)

Facility

Other inspections at this facility

  • 1230565 (VAI Fri Mar 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1155063 (VAI Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1106821 (VAI Fri Oct 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030807 (NAI Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983604 (VAI Fri Aug 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources